Targeting LIN28: a new hope in prostate cancer theranostics

Shrivastava, Garima, Aljabali, Alaa AA, Shahcheraghi, Seyed Hossein, Lotfi, Marzieh, Shastri, Madhur D, Shukla, Shakti D, Chellappan, Dinesh K, Jha, Niraj Kumar, Anand, Krishnan et al (2021) Targeting LIN28: a new hope in prostate cancer theranostics. Future Oncology, 17 (29). ISSN 1479-6694

[thumbnail of Version of Record]
PDF (Version of Record) - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.


Official URL:


The mortality and morbidity rates for prostate cancer have recently increased to alarming levels, rising higher than lung cancer. Due to a lack of drug targets and molecular probes, existing theranostic techniques are limited. Human LIN28A and its paralog LIN28B overexpression are associated with a number of tumors resulting in a remarkable increase in cancer aggression and poor prognoses. The current review aims to highlight recent work identifying the key roles of LIN28A and LIN28B in prostate cancer, and to instigate further preclinical and clinical research in this important area.

Repository Staff Only: item control page